When SiHa cells were treated with PTX + CIS, mRNA expression levels of P53 and PUMA, and P16 were 1.3- to 3-fold up-regulated, while in CASPASES-3, -9, NOXA and P21 we found > 3-fold up-regulation. The gene discussed is TP53; the disease is in situ carcinoma.